Oppenheimer downgraded RXO, Inc. from Outperform to Perform
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/4/2025 | Outperform → Perform | Oppenheimer | |
| 3/13/2025 | $24.00 | Buy | Truist |
| 3/7/2025 | $19.00 | Hold | Deutsche Bank |
| 11/18/2024 | $29.00 | Neutral | Goldman |
| 11/12/2024 | $33.00 | Buy → Neutral | Citigroup |
| 11/11/2024 | $31.00 | Equal Weight | Wells Fargo |
| 10/9/2024 | $33.00 | Buy | Citigroup |
| 5/15/2024 | Mkt Perform | Raymond James |
4 - RXO, Inc. (0001929561) (Issuer)
4 - RXO, Inc. (0001929561) (Issuer)
4 - RXO, Inc. (0001929561) (Issuer)